Tag Archives: Lupus

August, 2018

July, 2018

May, 2018

July, 2017

June, 2017

January, 2017

  • 30 January

    Celgene to Acquire Autoimmune Disease Startup Delinia

    SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Delinia, Inc. (“Delinia”), a privately held biotechnology company developing novel therapeutics for autoimmune diseases, today announced that they have entered into an agreement for the acquisition of Delinia by Celgene. The transaction expands Celgene’s Inflammation and Immunology pipeline through …

December, 2016

  • 16 December

    Investigating Kidney Biomarkers to Track Lupus

    ANN ARBOR, Mich. – Lupus, a chronic autoimmune disease, can wreak havoc on an affected individual’s body through inflammation, pain and even damage of the skin, joints and organs. To try to better understand how the disease begins and progresses, researchers at the University of Michigan investigated whether kidney biomarkers …

August, 2016

March, 2016

November, 2015

  • 11 November

    AstraZeneca’s Lupus Drug Succeeds in Mid-Stage Study

    AstraZeneca, along with its global biologics research and development arm, MedImmune, will present positive data today from the Phase II trial of anifrolumab for the treatment of moderate-to-severe systemic lupus erythematosus (SLE or lupus) at the American College of Rheumatology (ACR) 2015 Annual Scientific Meeting in San Francisco. Trial results …